§ — Market briefing
A $1.2 billion category, on a 9.1% CAGR through 2034.
An editorial briefing on the global medical-grade honey market — size, segments, channels, end-users, structural drivers and the competitors that matter — with the caveats they deserve.
§ I — Headline
The category at a glance.
$1.2B
Global market
Base year 2025
$2.6B
Forecast value
2034
9.1%
CAGR
2026–2034
47.8%
Wound-care share
of applications, 2025
§ II — Trajectory
Size & forecast, 2019 → 2034.
Historical growth has compounded at ~7%; analysts model an acceleration to 9.1% as wound-care reimbursement broadens and Asia Pacific scales.
§ III–VIII — Full briefing
Regions, segments, channels, drivers and competitors.
Sign in free for the full briefing: regional shares, product and application split, sales channels, growth drivers, opportunities and threats, and the competitive landscape.
How strength is graded
MGO 200+ for general wound maintenance. MGO 300+ for more active wound management.
Up to MGO 200
Skin care, consumer wellness, lozenges and syrups.
MGO 200+
General wound maintenance — the everyday MGH™ tier.
MGO 300+
More active wound management — our higher-strength tier.
FDA / TGA-registered medical devices must hold standardised MGO content batch to batch — a guarantee unregistered consumer honey does not provide.
Sources & methodology
A synthesis across multiple analyst houses — not a single republished report.
The figures on this page are a paraphrased synthesis of publicly available analyst coverage of the medical-grade honey category. Estimates differ between firms; numbers here represent the central range across published sources, not the exact figures of any one provider. Where a single house is the outlier, the consensus is preferred.
Industry analysts (market sizing)
- · Dataintelo — Global Medical Grade Honey Market 2025–2034
- · Grand View Research — Medical Grade Honey Market Size & Share Report
- · Fortune Business Insights — Medical Grade Honey Market
- · Mordor Intelligence — Medical Grade Honey Market Outlook
- · Polaris Market Research — Medical Grade Honey Market
Primary & clinical context
- · IDF Diabetes Atlas — diabetes & DFU prevalence
- · WHO & ECDC — AMR burden
- · IWGDF — diabetic foot ulcer guidelines
- · NICE / BNF — UK formulary positioning
- · WUWHS & EWMA — wound-care consensus documents
- · Comvita, Manuka Health, Capilano, Triticum — published annual reports & investor disclosures
Editorial note. All figures, tables and commentary on this page are paraphrased from publicly available sources and represent independent editorial synthesis. No charts, tables or verbatim text have been reproduced from any single proprietary report. Figures are directional — for a defensible, indication-specific market view (e.g. for an investment memo, regulatory filing or board paper), commission a tailored briefing.